|Application ||WB, IHC-P, E|
|Calculated MW||31546 Da|
|Antigen Region||15-42 aa|
|Other Names||Interferon-induced 35 kDa protein, IFP 35, Ifi-35, IFI35, IFP35|
|Target/Specificity||This IFI35 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 15-42 amino acids from the N-terminal region of human IFI35.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||IFI35 Antibody (N-term R30) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Not yet known.|
|Cellular Location||Nucleus. Note=Nuclear following IFN treatment|
|Tissue Location||In a wide range of cell types, including fibroblasts, macrophages, and epithelial cells|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Inhibins and activins inhibit and activate, respectively, the secretion of follitropin by the pituitary gland. Inhibins/activins are involved in regulating a number of diverse functions such as hypothalamic and pituitary hormone secretion, gonadal hormone secretion, germ cell development and maturation, erythroid differentiation, insulin secretion, nerve cell survival, embryonic axial development or bone growth, depending on their subunit composition. Inhibins appear to oppose the functions of activins.
Johnatty, S.E., et al. PLoS Genet. 6 (7), E1001016 (2010) :
Wang, J., et al. J. Proteome Res. 7(9):3879-3889(2008)
Tan, J., et al. J. Virol. 82(9):4275-4283(2008)
Zhang, L., et al. Cell. Signal. 19(5):932-944(2007)
Oh, J.H., et al. Mamm. Genome 16(12):942-954(2005)
If you have any additional inquiries please email technical services at email@example.com.